Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease
Chandni Pathak, Uma D. Kabra
Bioorganic Chemistry (2024) Vol. 144, pp. 107152-107152
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

New Brusatol Derivatives as Anti-Settlement Agents Against Barnacles, Targeting HSP90: Design, Synthesis, Biological Evaluation, and Molecular Docking Investigations
Jiang Wang, Tongtong Luan, Pei Cao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 593-593
Open Access
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Synthesis of new fluorinated sulfonates and their Schiff bases as anti-Alzheimer drug candidates: An in vitro-in silico study
Reşit Çakmak, Eyüp Başaran, Selami Ercan, et al.
Journal of Molecular Structure (2025), pp. 141474-141474
Closed Access
1,3,5-Triazine: A Promising Molecular Scaffold for Novel Agents for the Treatment of Alzheimer’s Disease
Carlos F. M. Silva, Ana P. D. de M. S. Guerrinha, Sofia Carvalho, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 882-882
Open Access
Exploring Quinazoline as a Scaffold for Developing Novel Therapeutics in Alzheimer’s Disease
Qais Abualassal, Zead Abudayeh, Ala’ Yahya Sirhan, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 555-555
Open Access
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 708-708
Open Access | Times Cited: 4
Impact of In Vitro Gastrointestinal Digestion on the Phenolic Bioaccessibility and Bioactive Properties of Insect-Containing Beef Burgers
Gabriele Rocchetti, Gökhan Zengin, Gianluca Giuberti, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 365-365
Open Access | Times Cited: 2
Rational design of a near-infrared fluorescent probe for monitoring butyrylcholinesterase activity and its application in development of inhibitors
Hao Li, Xiaodong Li, Chao-Hua Yan, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 2
Recent advances in the natural product analogues for the treatment of neurodegenerative diseases
Jinling Zhang, Peng Jiang, Shuping Wang, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107819-107819
Closed Access | Times Cited: 1
Sulforaphane (4-methylsulfnylbutyl isothiocyanate) mitigates gold nanoparticle induced brain toxicity in male albino rats
Wafa S. Alansari
Journal of King Saud University - Science (2024) Vol. 36, Iss. 7, pp. 103257-103257
Open Access | Times Cited: 1
Improved Affinity: A Customized Fluorescent Probe for the Rapid Detection of Butyrylcholinesterase
Wei Wang, Xiaofei Chen, Yi Zhang, et al.
Chemosensors (2024) Vol. 12, Iss. 6, pp. 100-100
Open Access | Times Cited: 1
Harnessing the Therapeutic Potential of Peptides for Synergistic Treatment of Alzheimer’s Disease by Targeting Aβ Aggregation, Metal-Mediated Aβ Aggregation, Cholinesterase, Tau Degradation, and Oxidative Stress
Kamaljot Singh, Anupamjeet Kaur, Bhupesh Goyal, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 14, pp. 2545-2564
Closed Access | Times Cited: 1
Design of Promising Thiazoloindazole-Based Acetylcholinesterase Inhibitors Guided by Molecular Docking and Experimental Insights
Fatima Laghchioua, Carlos F. M. Silva, Diana C. G. A. Pinto, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 15, pp. 2853-2869
Open Access | Times Cited: 1
Design, synthesis, and biological evaluation of tetrahydropyrimidine analogue as GSK-3β/Aβ aggregation inhibitor and anti-Alzheimer’s agent
Sukanya Sukanya, Aina Bellver‐Sanchís, Bhanwar Singh Choudhary, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107811-107811
Closed Access | Times Cited: 1
Advances in Understanding Biomarkers and Treating Neurological Diseases -Role of the Cerebellar Dysfunction and Emerging Therapies
Azhagu Madhavan Sivalingam
Ageing Research Reviews (2024), pp. 102519-102519
Closed Access | Times Cited: 1
Membrane interactions in Alzheimer’s disease treatment strategies with multitarget molecules
Pablo Zambrano
Bioorganic Chemistry (2024) Vol. 147, pp. 107407-107407
Closed Access
Discovery of Structurally Intriguing Hache Inhibitors from Tropic Rhodomyrtus Tomentosa Leaves: Isolation, Configuration Assignment, Hache Inhibitory Activities, and Molecular Docking Studies
Ling‐Yun Chen, E-E Luo, Yu Pan, et al.
(2024)
Closed Access
One flask cascade approach to complex pyrano[2,3-c]pyrazole-pyrazolone hybrid heterocyclic system and its initiatory neurobiological profiling
Alagesan Balasubramani, K. A. Sudarshana, R. A. S. Kushwaha, et al.
Chemical Communications (2024) Vol. 60, Iss. 64, pp. 8443-8446
Closed Access
Stepwise Structural Simplification of the Dihydroxyanthraquinone Moiety of a Multitarget Rhein-Based Anti-Alzheimer Lead to Improve Drug Metabolism and Pharmacokinetic Properties
Caterina Pont, Anna Sampietro, F. Javier Pérez-Areales, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 982-982
Open Access
Edaravone N-benzyl pyridinium derivatives: BACE-1 inhibition, kinetics and in silico binding pose determination
Luke S. Zondagh, Sarel F. Malan, Jacques Joubert
European Journal of Pharmaceutical Sciences (2024) Vol. 201, pp. 106869-106869
Open Access
Efficient Two-Step Synthesis of Novel Pyrimido[4,5-d] Pyrimidines with Potent Neuroprotective, Antioxidant, and Aβ Anti-Aggregation Properties
Ghada Ben Ameur, Emna Maalej, Hélène Martin, et al.
Chemistry (2024) Vol. 6, Iss. 4, pp. 695-705
Open Access
Acetylcholinesterase inhibitory phloroglucinols from tropic Rhodomyrtus tomentosa
Lingyun Chen, E-E Luo, Yu Pan, et al.
Phytochemistry (2024) Vol. 228, pp. 114254-114254
Closed Access
Advances in Cholinesterase Inhibitor Research—An Overview of Preclinical Studies of Selected Organoruthenium(II) Complexes
Monika C. Žužek
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9049-9049
Open Access
Multitarget-Directed Ligands Hitting Serotonin Receptors: A Medicinal Chemistry Survey
Imane Ghafir El Idrissi, A. Di Santo, Enza Lacivita, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1238-1238
Open Access
Multi-omics reveals changes in astrocyte fatty acid metabolism during early stages of Alzheimer's disease
Jie Zhong, Manhui Li, Ziwei Dai, et al.
Research Square (Research Square) (2024)
Closed Access
Page 1 - Next Page

Scroll to top